ESC 365 - Identification of clinical risk factors and biological markers associated with development of atrial low voltage substrate predisposing to atrial fibrillation. Substrate-AF-Study

EHRA Premium Access

Identification of clinical risk factors and biological markers associated with development of atrial low voltage substrate predisposing to atrial fibrillation. Substrate-AF-Study

Session: Poster session 1 - Atrial fibrillation ablation - Mechanisms and outcomes

Topic: Arrhythmias, General – Epidemiology, Prognosis, Outcome

Speaker: Doctor Z. Moreno Weidmann (Barcelona, ES)

Event: EHRA 2018

Congress Presentation

Add to my library

About the speaker

Doctor Zoraida L Moreno Weidmann

Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

0 follower

33 more presentations in this session

Transformation in rotational atrial activity before and after pulmonary vein isolation

Speaker: Professor T. Neumann (Nauheim, DE)

Safety of rapid ventricular pacing to acquire three-dimensional rotational angiography during ablation of atrial fibrillation

Speaker: Doctor A. Billiet (Leuven, BE)

Epicardial ligation of the left atrial appendage for antiarrhythmic indication

Speaker: Doctor K. Nentwich (Bad Neustadt an der Saale, DE)

Force-Time Integral (FTI) values can predict transmural lesions in left atrium after pulmonary vein isolation in cardiac MRI 3 months post-ablation

Speaker: Doctor M. Forkmann (Coburg, DE)

Impact of catheter ablation and characteristics of patients with atrial fibrillation and reduced ejection fraction

Speaker: Doctor A. Vevecka (Würzburg, DE)

Access the full session

Poster session 1 - Atrial fibrillation ablation - Mechanisms and outcomes

Speakers: Doctor Z. Moreno Weidmann, Professor T. Neumann, Doctor A. Billiet, Doctor K. Nentwich, Doctor M. Forkmann...

About the event

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources